Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.23.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Accounts payable:    
Clinical and regulatory expenses $ 499 $ 361
Professional fees 618 626
Selling expenses 1,210 1,363
Manufacturing costs 364 650
Non-employee director compensation 620 484
Other vendors 130 301
Total accounts payable 3,441 3,785
Accrued interest payable, related parties 525 144
Accrued interest payable 2,278 2,381
Accrued expenses:    
Payroll expenses 1,868 1,263
Government rebates and other rebates 5,341 5,536
Due to customers 844  
Other accrued expenses 903 440
Total accrued expenses 8,956 7,239
Total accounts payable and accrued expenses $ 15,200 $ 13,549